Revision as of 16:21, 29 July 2010 editPotatoBot (talk | contribs)Bots51,239 editsm Stub sorting and placement of stub template(s)← Previous edit | Revision as of 07:37, 17 January 2011 edit undoPashihiko (talk | contribs)Extended confirmed users3,563 editsNo edit summaryNext edit → | ||
Line 7: | Line 7: | ||
| PubChem = 33675 | | PubChem = 33675 | ||
| DrugBank = | | DrugBank = | ||
| KEGG = D07266 | |||
| C=19|H=17|Cl=1|N=2|O=4 | | C=19|H=17|Cl=1|N=2|O=4 | ||
| molecular_weight = 372.80228 g/mol | | molecular_weight = 372.80228 g/mol |
Revision as of 07:37, 17 January 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
PubChem CID | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.043.785 |
Chemical and physical data | |
Formula | C19H17ClN2O4 |
Molar mass | 372.80228 g/mol g·mol |
Oxametacin (or oxamethacin) is a non-steroidal anti-inflammatory drug.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |